Literature DB >> 35059116

Novel Compounds for Targeted Degradation of BRD9 and Their Use for Treating Cancer.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 35059116      PMCID： PMC8762736          DOI： 10.1021/acsmedchemlett.1c00658

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors.

Authors:  Oliver Bechter; Patrick Schöffski
Journal:  Pharmacol Ther       Date:  2020-01-11       Impact factor: 12.310

Review 2.  Bromodomains: A novel target for the anticancer therapy.

Authors:  Shivani Gokani; Lokesh Kumar Bhatt
Journal:  Eur J Pharmacol       Date:  2021-09-23       Impact factor: 4.432

Review 3.  Targeting BRD9 for Cancer Treatment: A New Strategy.

Authors:  Xiuzuo Zhu; Yi Liao; Liling Tang
Journal:  Onco Targets Ther       Date:  2020-12-24       Impact factor: 4.147

Review 4.  The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.

Authors:  Motoyuki Tsuda; Akihisa Fukuda; Munenori Kawai; Osamu Araki; Hiroshi Seno
Journal:  Cancer Sci       Date:  2020-12-28       Impact factor: 6.716

Review 5.  Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class.

Authors:  Francesca D'Amico; Rishov Mukhopadhyay; Huib Ovaa; Monique P C Mulder
Journal:  Chembiochem       Date:  2021-03-18       Impact factor: 3.164

Review 6.  Exploiting epigenetic dependencies in ovarian cancer therapy.

Authors:  Aisling Y Coughlan; Giuseppe Testa
Journal:  Int J Cancer       Date:  2021-08-06       Impact factor: 7.316
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.